These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 28087162)

  • 21. Melatonin exerts by an autocrine loop antiproliferative effects in cholangiocarcinoma: its synthesis is reduced favoring cholangiocarcinoma growth.
    Han Y; Demorrow S; Invernizzi P; Jing Q; Glaser S; Renzi A; Meng F; Venter J; Bernuzzi F; White M; Francis H; Lleo A; Marzioni M; Onori P; Alvaro D; Torzilli G; Gaudio E; Alpini G
    Am J Physiol Gastrointest Liver Physiol; 2011 Oct; 301(4):G623-33. PubMed ID: 21778461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-124 targets GATA6 to suppress cholangiocarcinoma cell invasion and metastasis.
    Tian F; Chen J; Zheng S; Li D; Zhao X; Jiang P; Li J; Wang S
    BMC Cancer; 2017 Mar; 17(1):175. PubMed ID: 28270130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Omega-3 Polyunsaturated Fatty Acids Upregulate 15-PGDH Expression in Cholangiocarcinoma Cells by Inhibiting miR-26a/b Expression.
    Yao L; Han C; Song K; Zhang J; Lim K; Wu T
    Cancer Res; 2015 Apr; 75(7):1388-98. PubMed ID: 25691459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decrease of miR-622 expression promoted the proliferation, migration and invasion of cholangiocarcinoma cells by targeting regulation of c-Myc.
    Wu YF; Li ZR; Cheng ZQ; Yin XM; Wu JS
    Biomed Pharmacother; 2017 Dec; 96():7-13. PubMed ID: 28961507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclophilin A enhances cell proliferation and tumor growth of liver fluke-associated cholangiocarcinoma.
    Obchoei S; Weakley SM; Wongkham S; Wongkham C; Sawanyawisuth K; Yao Q; Chen C
    Mol Cancer; 2011 Aug; 10():102. PubMed ID: 21871105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulated circular RNA hsa_circ_0001649 regulates proliferation, migration and invasion in cholangiocarcinoma cells.
    Xu Y; Yao Y; Zhong X; Leng K; Qin W; Qu L; Cui Y; Jiang X
    Biochem Biophys Res Commun; 2018 Feb; 496(2):455-461. PubMed ID: 29337065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Akirin2 is modulated by miR-490-3p and facilitates angiogenesis in cholangiocarcinoma through the IL-6/STAT3/VEGFA signaling pathway.
    Leng K; Xu Y; Kang P; Qin W; Cai H; Wang H; Ji D; Jiang X; Li J; Li Z; Huang L; Zhong X; Sun X; Wang Z; Cui Y
    Cell Death Dis; 2019 Mar; 10(4):262. PubMed ID: 30886152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of transforming growth factor β1 promotes cholangiocarcinoma development and progression.
    Huang CK; Aihara A; Iwagami Y; Yu T; Carlson R; Koga H; Kim M; Zou J; Casulli S; Wands JR
    Cancer Lett; 2016 Sep; 380(1):153-62. PubMed ID: 27364974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-182-5p promotes the proliferation and invasion of hilar cholangiocarcinoma cells by inhibiting FBXW7.
    Zhou H; Jiang Y; Zhou Y; Zhang Z; Li S
    J Cancer Res Clin Oncol; 2024 Oct; 150(10):461. PubMed ID: 39402299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin receptor blocker telmisartan inhibits cell proliferation and tumor growth of cholangiocarcinoma through cell cycle arrest.
    Samukawa E; Fujihara S; Oura K; Iwama H; Yamana Y; Tadokoro T; Chiyo T; Kobayashi K; Morishita A; Nakahara M; Kobara H; Mori H; Okano K; Suzuki Y; Himoto T; Masaki T
    Int J Oncol; 2017 Dec; 51(6):1674-1684. PubMed ID: 29075786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and Clinical Pathological Significance of miR-200a in Concurrent Cholangiocarcinoma Associated with Hepatolithiasis.
    Chen C; Yang D; Wang Q; Wang X
    Med Sci Monit; 2015 Nov; 21():3585-90. PubMed ID: 26586458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The long noncoding RNA DLGAP1-AS2 facilitates cholangiocarcinoma progression via miR-505 and GALNT10.
    Liu Z; Pan L; Yan X; Duan X
    FEBS Open Bio; 2021 Feb; 11(2):413-422. PubMed ID: 33301605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-26a induced the suppression of tumor growth of cholangiocarcinoma via KRT19 approach.
    Wang P; Lv L
    Oncotarget; 2016 Dec; 7(49):81367-81376. PubMed ID: 27833076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sirtuin7 has an oncogenic potential via promoting the growth of cholangiocarcinoma cells.
    Li W; Sun Z; Chen C; Wang L; Geng Z; Tao J
    Biomed Pharmacother; 2018 Apr; 100():257-266. PubMed ID: 29438839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of lncRNA PVT1/miR186/KLF5 Axis on the Occurrence and Progression of Cholangiocarcinoma.
    Sun Q; Gong X; Wu J; Hu Z; Zhang Q; Gong J; Zhu X
    Biomed Res Int; 2021; 2021():8893652. PubMed ID: 34337058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA‑137 suppresses the proliferation, migration and invasion of cholangiocarcinoma cells by targeting WNT2B.
    Chen T; Lei S; Zeng Z; Pan S; Zhang J; Xue Y; Sun Y; Lan J; Xu S; Mao D; Guo B
    Int J Mol Med; 2020 Mar; 45(3):886-896. PubMed ID: 31985024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-378 serves as a prognostic biomarker in cholangiocarcinoma and promotes tumor proliferation, migration, and invasion.
    Zhou Z; Ma J
    Cancer Biomark; 2019; 24(2):173-181. PubMed ID: 30594918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genome-wide screen identified let-7c/miR-99a/miR-125b regulating tumor progression and stem-like properties in cholangiocarcinoma.
    Lin KY; Ye H; Han BW; Wang WT; Wei PP; He B; Li XJ; Chen YQ
    Oncogene; 2016 Jun; 35(26):3376-86. PubMed ID: 26455324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Let-7c inhibits cholangiocarcinoma growth but promotes tumor cell invasion and growth at extrahepatic sites.
    Xie Y; Zhang H; Guo XJ; Feng YC; He RZ; Li X; Yu S; Zhao Y; Shen M; Zhu F; Wang X; Wang M; Balakrishnan A; Ott M; Peng F; Qin RY
    Cell Death Dis; 2018 Feb; 9(2):249. PubMed ID: 29445149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma.
    Di Matteo S; Nevi L; Costantini D; Overi D; Carpino G; Safarikia S; Giulitti F; Napoletano C; Manzi E; De Rose AM; Melandro F; Bragazzi M; Berloco PB; Giuliante F; Grazi G; Giorgi A; Cardinale V; Adorini L; Gaudio E; Alvaro D
    PLoS One; 2019; 14(1):e0210077. PubMed ID: 30677052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.